Fresenius Stock - Chart picture around the 200-day line
18.06.2026 - 21:16:50 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 21:15 CET. Details in the imprint.
Fresenius (DE0005785604) is one of the established German healthcare stocks in the Standard & Poor's 500 index’s European peer universe via its DAX membership, even if it is not part of the U.S. benchmark itself. On this technical Thursday, the focus is on how the shares currently trade around their medium-term trend on Xetra.
All news and key data on Fresenius stock
Here you can find additional background, ad hoc disclosures and price information on Fresenius alongside this descriptive technical snapshot.
What current quotes show
On the German platform Finanzen100, Fresenius shares are quoted around EUR 38.42 for the latest trading day, with the day’s low also reported at EUR 38.42, underscoring a relatively tight intraday range. The WKN is 578560 and the ticker on Xetra is FRE.
The stock remains part of the DAX index, which groups 40 of the largest German companies by market capitalization and free float, anchoring Fresenius in the core of the domestic blue-chip universe. This index membership keeps the stock on the radar of passive funds and benchmark-oriented investors.
Chart levels and 200-day line
Viewed over the past 12 months on common charting portals such as finanzen.net and TradingView, Fresenius shares have moved in a broad corridor roughly between EUR 25 and EUR 40. The recent quote around the upper end of this band points to a robust recovery compared with last year’s lows.
On many daily charts the 200-day moving average now runs in the mid-30s in euro terms, so the current price sits somewhat above this medium-term trend indicator. Technicians often interpret sustained trading above a rising 200-day line as a sign of a constructive longer-term picture, without this implying any forecast.
Thursday focus on technicals
Because today is Thursday, this review deliberately concentrates on the descriptive technical situation rather than on new corporate news or analyst actions. The emphasis lies on levels, moving averages and volatility, not on future scenarios.
Over the past weeks, daily price swings in Fresenius shares have mostly stayed in a low single-digit percentage range, reflecting relatively muted volatility compared with more cyclical stocks. For many investors, that stability complements the defensive healthcare profile, even if single news days can still bring sharper moves.
How Fresenius makes its money
Fresenius generates most of its revenue as a diversified healthcare group with four major businesses: hospital operator Helios, infusion and nutrition specialist Kabi, generic and biosimilar provider Fresenius Kabi, and its stake in dialysis operator Fresenius Medical Care according to company information. The group focuses on acute care, chronic care and related services in Europe and beyond.
Where the stock trades today
The shares of Fresenius (DE0005785604) trade on Xetra at EUR 38.42 as of 06/18/2026, 21:15 CET.
Key facts on Fresenius stock
- Company: Fresenius SE & Co. KGaA
- ISIN: DE0005785604
- WKN: 578560
- Ticker: FRE
- Venue: Xetra
- Price (as of 06/18/2026, 21:15 CET): 38.42 EUR
- Market cap: 21,000,000,000 EUR (as of 06/18/2026)
- Sector / Industry: Health Care / Health Care Providers & Services
- Index membership: DAX
- Next earnings date: 08/01/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
